New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison

Published:2020-11-09 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Bonnet Raphaël,Nebout Marielle,Brousse Carine,Reinier Frédéric,Imbert Véronique,Rohrlich Pierre Simon,Peyron Jean-François

Funder

Institut National de la Santé et de la Recherche Médicale

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference42 articles.

1. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration;Pui;J Clin Oncol,2015

2. Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia;Petit;Blood,2018

3. How I treat T-cell acute lymphoblastic leukemia in adults;Litzow;Blood,2015

4. How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children;Teachey;Blood,2020

5. Can one target T-cell ALL;Ferrando;Best Pract Res Clin Haematol,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro synergistic antiviral activity of repurposed drugs against enterovirus 71;Archives of Virology;2024-07-30

2. In silico approaches for drug repurposing in oncology: a scoping review;Frontiers in Pharmacology;2024-06-11

3. Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities;Annals of Hematology;2024-06-05

4. Antipsychotic Prochlorperazine Restrains Bladder Cancer Growth by Regulating cell proliferation and SRC-MEK-ERK Pathway;2023-10-12

5. Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer;Neuroscience & Biobehavioral Reviews;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3